Skip to main content
Skip to footer
Contact Us
We are taking you to another website now.

Using TCS 5I Model to Strengthen Drug Safety and Make it Patient-Centric

TCS 5i model future proofs the drug safety sector to service patients better.

TCS 5i framework re-imagines the drug safety landscape and presents a unified approach to address the challenges in following way: it integrates insights, inquires and works with R&D to gain relevant information, identifies safety concerns, improves show risks are addressed, and informs by devising a communication strategy.

Scientific advancements & digital technologies have created new opportunities for modernizing drug safety.

Debashis Ghosh

President – Life Sciences, Healthcare, Government and Energy Business Group, TCS

Amit Saxena

Head - Strategic Initiatives, Life Sciences, TCS

Dr. Rajgopal Srinivasan

Prinicipal Scientist, Head of Bio-IT R&D Innovation Labs, Hyderabad, TCS

Anil Lele

Head, Pharmaceutical Analytics Services Life Sciences Business Unit, TCS


Thank you for downloading

Your opinion counts! Let us know what you think by choosing one option below.